de Vries Annelou L C, Klink Daniel, Cohen-Kettenis Peggy T
Department of Child and Adolescent Psychiatry, VU University Medical Center, Room 1y130, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Division of Endocrinology, Department of Pediatrics, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Pediatr Clin North Am. 2016 Dec;63(6):1121-1135. doi: 10.1016/j.pcl.2016.07.011. Epub 2016 Oct 14.
The recognition and acknowledgment that gender identity and birth-assigned sex may be incongruent in children and adolescents have evolved in recent decades. Transgender care for children and adolescents has developed and is now more widely available. Controversies exist, however, around clinical management of gender dysphoria and gender incongruence in children and adolescents. Clinical guidelines are consensus based and research evidence is limited. Puberty suppression as part of clinical management has become a valuable element of adolescent transgender care, but long-term evidence of success is limited. These uncertainties should be weighed against the risk of harming a transgender adolescent when medical intervention is denied.
近几十年来，人们对儿童和青少年中性别认同与出生时指定的性别可能不一致的认识和认可有所发展。针对儿童和青少年的跨性别护理已经出现，并且现在有了更广泛的可及性。然而，围绕儿童和青少年性别焦虑症及性别不一致的临床管理存在争议。临床指南基于共识，而研究证据有限。作为临床管理一部分的青春期抑制已成为青少年跨性别护理的一个重要组成部分，但长期成功的证据有限。在拒绝医疗干预时，应权衡这些不确定性与伤害跨性别青少年的风险。
